Yi-Lin Chao

Yi-Lin Chao practices at Austin Regional Clinic, PA in Liberty Hill, Texas.

Yi-Lin Chao's NPI, 1568194413, was assigned on June 29, 2022.

Yi-Lin Chao's primary practice is Austin Regional Clinic, PA, at 12779 W State Highway 29, Liberty Hill, TX 78642 in Williamson County. The practice phone is (512) 231-5516.

Yi-Lin Chao's primary practice is Austin Regional Clinic, PA in Liberty Hill, Texas. The medical group on file is Austin Regional Clinic (ARC). Dmand AI also links Yi-Lin Chao to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Yi-Lin Chao practices. Vendor and product names are available with a free account.

Physician assistant is Yi-Lin Chao's primary specialty in the NPI Registry, under taxonomy code 363A00000X.

Dmand AI lists acute sinusitis, acute skin infection, arthritis, chronic kidney disease, diabetic emergency, enlarged prostate, gout and joint pain among the conditions Yi-Lin Chao treats.

CMS data shows 337 Medicare services from Yi-Lin Chao across 9 procedure codes in 2024, for 162 Medicare patients. Medicare paid $15,164 for them. Every service was in an office.

CMS counts 162 Medicare patients who saw Yi-Lin Chao in 2024. The largest group is 65 to 74, with 58 patients. 71% of them have high cholesterol, and 67% have high blood pressure. 46% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Yi-Lin Chao's median patient age at 42, with 51% women.

In 2024, Yi-Lin Chao wrote 1,793 Medicare Part D claims for 534 patients. 89% of them were for generic drugs. CMS names the drug for 1,298 of them, across 43 drugs with 11 or more claims each, at $52,266 in total drug cost.

Yi-Lin Chao accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 17 general payments to Yi-Lin Chao from 10 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $82.